chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day 2: Sore arm , fever, cold sweat, body aches , fatigue headaches  Day 3: sore arm, fever , cold sweats , body aches , fatigue, sore throat, headaches .  Day 4: sore arm , sore throat, pain in chest taking deep breath , chest tightness, heart racing ,  easily winded .  Bpm dropped to 40 at 5am then back up (not normal for me)  Day 5 & 6: slight pain in chest and throat area when taking deep breathes , easily winded, , heart racing, neck pain .unexplainable feeling in chest not painful but present. Bpm dropped to 40 again once during the night of 5th night.  Headache .  Day 7: feel mostly back to normal except woke up to neck pain , pain in neck and throat when taking deep breath , easily winded, slight headache on and off.
All the classic systems of PMR . Doctors at the Urgent Care diagnosis was PMR and I was called into The Medical Center, and the Doctor also said it was PMR at which time she put me on Prednisone.
First symptoms were immediate. My left forearm ached for several days. The next day my right calf felt like I was kicked.  20 days after the second shot I had a syncope vasa vagal event when I got up in the middle of the night to urinate.  That was preceded by a rapid heart beat that night while laying in bed. I have palpitations so I am accustomed to irregular beats. But this was different from a palpitation.
Information has been received from a physician concerning a 16 week old full term female with no medical history or allergies who on 10/23/2006 was vaccinated PO with the first dose of Rotavirus vaccine (lot 654663/0942F). Concomitant vaccinations administered on that same day included a dose of Prevnar and a dose of Hib vaccine. The physician reported that on 10/23/06, the pt developed severe watery, large volume diarrhea and a fever of 101F. On 10/26/06, the pts fever resolved. On 10/27/2006, the pt was examined in the ER where she was given acetaminophen and diaper rash ointment. It was also noted that the pt had developed a secondary yeast infection. On 11/7/06, the pts diarrhea and yeast infection resolved. The physician considered diarrhea, fever and yeast infection to be disabling. Additional information has been requested.
Mother states that approx. 5 hrs after giving baby shots, she noticed swelling underneath both eyes. She also states that she noticed baby rubbing her eyes. no redness or fever noted and swelling had improved. On examination of eyes, no redness noted. Skin cool to touch, only slight swelling or puffiness noted. Baby didn't appear restless, irritated or crying. Advised Motrin. If eyes swelling persist or worsen to take child to ER.
Soreness at injection site, body aches, tired ness, fever of 100.3 (reported on Monday 12/13/21), chills
2 days  after I was vaccinated I felt dizzy(vertigo) my  blood pressure and temperature were normal. I went  to bed and woke up with ringing in my ears that has not stopped since then.   I never had tinnitus during the day. Occasionally I would notice very mild ringing at night before I would fall asleep when the room was very quiet.  This has not stopped since I first noticed it Thursday night.  It seems to be more in my right ear than my left.
Patient is a 78-year-old female who presented to Hospital Emergency Room with a 2-day history of generalized lethargy. She has had cough, fever, and mild shortness of breath without chest discomfort, nausea, vomiting, or abdominal pain. Her COVID PCR was positive.  A 1-view chest x-ray was consistent with tight patchy bilateral airspace disease consistent with COVID pneumonia.  She is hemodynamically stable, mildly tachypneic.  She presented initially with a temperature of 102.7.  Initial BUN and creatinine were elevated at 20 and 1.23 respectively. Tested positive on 11/26/2021.
Headache; Chills; Nausea; Vomiting; Body aches; Cold hands and feet; Muscle and joint pain; Muscle and joint pain; Jaw pain; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021, the patient experienced headache, chills, nausea, vomiting, body aches, cold hands and feet, muscle and joint pain and jaw pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events headache, chills, nausea, vomiting, body aches, cold hands and feet, muscle and joint pain and jaw pain was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a consumer via call center representative and described the occurrence of vomiting in a 58-year-old female patient who received SHINGRIX for prophylaxis. On 8th October 2018, the patient received the 1st dose of SHINGRIX (intramuscular) 50 µg. On 16th October 2018, 8 days after receiving SHINGRIX, the patient experienced vomiting, stomach pain, unable to eat, leg pain and feeling unwell. On 18th October 2018, the patient experienced dehydration and weight loss. On an unknown date, the patient experienced shingles and rash. The patient was treated with Pain Medication and Intravenous Fluids. On an unknown date, the outcome of the vomiting, stomach pain, unable to eat, leg pain, dehydration, shingles, rash, feeling unwell and weight loss were recovered/resolved. It was unknown if the reporter considered the vomiting, stomach pain, unable to eat, leg pain, dehydration, shingles, rash, feeling unwell and weight loss to be related to SHINGRIX. Additional details were reported as follows: A few days after vaccination the patient felt ill with vomiting, stomach pain, a terrible pain in her leg and she could not eat. She went to the emergency room on 18th October 2018, a couple days after the symptoms started and she was diagnosed with dehydration (she had lost 5 pounds in 3 days) and given intravenous fluids and pain medication. She did not vomit anymore, but she still could not eat through the weekend, then she developed a rash on her right leg from the top of her knee to her thigh, about 3 by 4 of the way around her leg. The rash occurred where she previously had the leg pain. The patient saw her physician and was diagnosed with shingles and started on treatment. The pain and rash had resolved, but she still had marks where the shingles developed. The reporter consented to follow up. Emergency room visit was required.
Information has been received from a health professional concerning a male pt who on 06Aug2002 was vaccinated with a dose of varicella virus vaccine live. On 23Apr2003 the pt developed break-through chickenpox. It was unknown if medical attention was sought. No product quality complaint was noted. It was also noted that 12 other pt's were vaccinated with a dose of varicella virus vaccine live and developed break-through chickenpox. Additional information has been requested.
Initial misuse report received from a healthcare professional on 07 June 2013. It was reported that a 15-year-old patient was administered DAPTACEL. No adverse event was reported. List of documents held by sender: none.
severe sore arm in limb it was given; nausea; fatigue; This is a spontaneous report from a non-contactable nurse (patient). A 37-year-old non-pregnant female patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot number and expiry date were unknown), intramuscular in the right arm on 23Dec2020 10:15 at a single dose for COVID-19 immunization. The patient has no other medical history. The patient has no known allergies. The patient has no COVID prior vaccination, and COVID was not tested post vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID), escitalopram oxalate (LEXAPRO), and vitamin c (ascorbic acid). The patient has no other vaccine in the past four weeks. On 23Dec2020 01:00 PM, the patient experienced severe sore arm in limb it was given (by nighttime she was almost unable to use her right arm, improved by next morning), nausea, and fatigue. The outcome of the events was recovered in Dec2020. No treatment was received for the adverse events. The report was considered non-serious.  No follow-up attempts are possible; Information about batch/lot number cannot be obtained. No further information is expected.
Complete loss of smell and taste; Complete loss of smell and taste; This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EN6205 and expiration date: not reported), via an unspecified route of administration, in Left Arm, on Feb2021 (at the age of 76-year-old) as DOSE 1, SINGLE, for covid-19 immunization in Pharmacy or Drug Store. Medical history included chronic obstructive pulmonary disease, asthma, hypertension, blood cholesterol, and penicillin allergy. Concomitant medications included hctz, atorvastatin, lisinopril, fluticasone propionate, salmeterol (WIXELA INHUB), albuterol (salbutamol). The patient was not pregnant at time of vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID -19 vaccine. The Patient had not been diagnosed with COVID-19 prior to vaccination and had been tested since the vaccination. The patient experienced complete loss of smell and taste on 14Mar2021. It was reported that events result in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included anosmia: smell test and computerized tomogram on unknown date, result unknown for both, sars-cov-2 test: negative   on 17Mar2021. Therapeutic measures were taken as a result of events included Flonase. The outcome of the events was Not recovered at time of report.  No follow-up attempts are needed. No further information is expected.
I was on vacation, I started feeling uncomfortable on my side like I was getting an UTI. I decided to pop into an urgent care to get medication to stop it before it got too bad. Upon examination, the doctor said that I needed to go to the emergency room to get my appendix area looked at with a CT scan and MRI. The hospital did an MRI and CT scan that revealed I needed to have my appendix removed. I stayed overnight in the hospital; they removed my appendix that morning and I was able to leave later that day.
Daily swelling of glands in throat /internal swelling in central portion of neck / throat; Throat discomfort; Neck discomfort; Inappropriate route of vaccination; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Daily swelling of glands in throat /internal swelling in central portion of neck / throat), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Inappropriate route of vaccination), OROPHARYNGEAL DISCOMFORT (Throat discomfort) and MUSCULOSKELETAL DISCOMFORT (Neck discomfort) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 025J20-2A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy and Hypothyroidism since 01-Jan-2003. Concomitant products included LEVOTHYROXINE from 01-Jan-2003 to an unknown date for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Inappropriate route of vaccination). On 05-Feb-2021, the patient experienced PHARYNGEAL SWELLING (Daily swelling of glands in throat /internal swelling in central portion of neck / throat), OROPHARYNGEAL DISCOMFORT (Throat discomfort) and MUSCULOSKELETAL DISCOMFORT (Neck discomfort). The patient was treated with IBUPROFEN ongoing from 05-Feb-2021 for Throat swelling, at a dose of UNK, prn. On 03-Feb-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Inappropriate route of vaccination) had resolved. At the time of the report, PHARYNGEAL SWELLING (Daily swelling of glands in throat /internal swelling in central portion of neck / throat) outcome was unknown and OROPHARYNGEAL DISCOMFORT (Throat discomfort) and MUSCULOSKELETAL DISCOMFORT (Neck discomfort) had not resolved.            Patient after receiving vaccine, patient experienced daily internal swelling in the central portion of my neck/throat. Patient said not a sore throat and there is no pain in swallowing. It is more of a slight strangulation type feeling.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Significant follow-up received 27Jul2021 contains throat discomfort and neck discomfort.
1 hour after shot severe back pain leaving patient unable to walk for 3 days, had to crawl. Day 5 developed a full severe body rash all over, requiring Benadryl, Pepcid around the clock, became so severe patient had to take a 3 day course of prednisone, rash resolved after 4 days. After rash, sore glands, earache, headache daily, light sensitivity, continuing back pain however not debilitating, symptoms still present 27 days post first shot .  Was advised not to get the second shot.
I woke up with a nasty cough in upper throat, not in lungs, felt like pharyngitis, but much worse. This lasted 24 hours. On day 3 I slept for 9 hours and then it was gone, 12/1. Televisit with doctor on 11/28, after testing positive on at home COVID-19 rapid test. Treated with DELSUM, VICKS, and cough drops.
Patient had syncope after injection.  Placed patient in recovery position and placed ice pack to back of neck. Patient waited an additional 10 minutes after gaining concussion before leaving.
since having the vaccine she is experiencing more pain with increased frequency; This is a spontaneous report from a sponsored program. A female patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history included from Oct2019 to current rheumatoid arthritis and she had been experiencing flare ups. The patient concomitant medications were not reported. On an unspecified date, the patient experienced since having the vaccine more pain with increased frequency. Patient reports MD placed her on hold from Xeljanz for 12 days to have the covid vaccines. Patient notes since the hold she had been experiencing flare ups, MD not aware patient advised to contacted MD. Patient restarted Xeljanz a few weeks ago. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Had significant painful axillary lymphadenopathy on the injection side; This is a spontaneous report from a contactable Other HCP. A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular at left arm on 11Jan2021 at single dose for COVID-19 immunization. None Medical history. No covid prior vaccination. The patient's concomitant medications were not reported. On 13Jan2021, patient had significant painful axillary lymphadenopathy on the injection side that resulted in doctor/other healthcare professional office visit. No treatment received. The event outcome was unknown. No covid tested post vaccination.  Information on the lot/batch number has been requested.
Information has been received from a 38 year old white female who on 1/16/99, was vaccinated with the 6th dose of Hep-B vaccine recombinant. Concomitant therapy included fluoxetine hydrochloride (Prozac), 10 mg for the last year. On 1/17/99, the pt experienced extreme fatigue, dizziness, headaches, a stiff neck, some constipation, fever and elevated blood pressure and pulse. Laboratory tests with normal results included a test for mononucleiosis, a thyroid function test, a complete blood cell count and a chem 7. Subsequently, the pt was treated with azithromycin (Zithromax) for 5 days for possible infection. The pt sought unspecified medical attention. No further information is available.
Pneumovax - Swollen, rash, restriction of movement. Started in evening lasted 4 days still itch 11/1/05. Fluarix - light headiness, sweating for 2 rest body. Temp of 108.3 degrees F. Ok today 10/28/05
Initial report received from a healthcare professional on 26 April 2013. A 29-year-old female patient had received an intramuscular first dose of ADACEL (Lot number:  U4612AA, site of administration was not reported) on 26 April 2013. The patient was pregnant at the time of vaccination. The last menstrual period date was 22 September 2012 and estimated date of delivery was 29 June 2013. As of 26 April 2013, the patient had not experienced any adverse event. The patient's health during pregnancy, concomitant medications, medical history and risk factors were not reported. Documents held by sender: none.
Patient called to pharmacy at about 11:30am to initially report that they had fainted and believed that they had undergone a seizure.
3 days after receiving booster dose I got vaginal ulcers that resulted in me going to the hospital. I was in another country at the time, I flew two days after my booster. I went to a hospital and they tested me for herpes to rule that out. I also got tested in the US for herpes since the foreign doctors lost my results. My herpes result was negative. Then two weeks after my booster I started getting foot inflammation and bumps across the top part of both of my feet. This has lasted since January and I still have them on my feet. I went to a dermatologist and they aren?t sure what caused it as I don?t have any other symptoms besides what my feet look like(no itching or burning). My vaginal ulcers lasted about 3-4 days before healing and becoming healed enough that  I could walk normally. The day I got my booster I received severe body aches and chills 4 hours after my booster which resulted in me not being able to work the next day. This lasted for a week of chills and body aches
chest pain  on left side of chest  & pain was radiating around to left side of his back
Muscle pain/Myalgia; Hot flash; This case was reported by a pharmacist via call center representative and described the occurrence of muscle pain in a 70-year-old female patient who received Herpes zoster (Shingrix) (batch number PF454, expiry date 26th January 2022) for prophylaxis.   On 10th December 2019, the patient received the 2nd dose of Shingrix (intramuscular). In December 2019, less than a day after receiving Shingrix, the patient experienced muscle pain and hot flashes. On an unknown date, the outcome of the muscle pain and hot flashes were recovering/resolving.   It was unknown if the reporter considered the muscle pain and hot flashes to be related to Shingrix.  Additional information was received as follows: The patient stated that around 2:30 am on the date of reporting she developed myalgia and muscle pains.  She was also having what feels like hot flashes.
Patient was given a dose of DTaP on 11/2/16, from a vial that had expired on 10/31/16.
Patient was given 2nd bivalent booster dose.  First dose was 9/23/22.
10 cm erythematous indurated lesion on thigh, developed 24-48 after immunization (L thigh).
Aches; Vomiting; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches), VOMITING (Vomiting) and CHILLS (Chills) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Aches), VOMITING (Vomiting) and CHILLS (Chills). At the time of the report, PAIN (Aches), VOMITING (Vomiting) and CHILLS (Chills) outcome was unknown.            No concomitant medication details was reported. No treatment medication details was reported. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-236539, MOD-2021-236555, MOD-2021-236569, MOD-2021-239232 (Patient Link).
allergies; This is a spontaneous report from a contactable 60-year-old female consumer reported for herself. A 60-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6207, Expiry date: unknown), via an unspecified route in lower forearm left on 17Mar2021 (age at vaccination: 60-year-old), as a single dose for covid-19 immunization. Medical history included shellfish reaction/allergies and arthritis in hip. Concomitant medications included loratadine 24-hour tablet, sold over the counter and acetylsalicylic acid (ASPIRIN) for arthritis in her hip. On an unknown date, patient was having some allergies last week and didn't think much about it/patient had allergies the week prior to the second dose, so she is unsure if her symptoms are from her allergies or the vaccine. The clinical outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
blood in urine; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 58-year-old non-pregnant female patient received bnt162b2 (Lot Number: 6206), dose 1 via an unspecified route of administration, administered in right arm on 12Mar2021 at 12:00 PM (at the age of 58 years old) as single dose for COVID-19 immunization. Medical history included asthma, thyroid, mild kidney disease, allergies, infertility, carpal tunnel, trigger finger, known allergies included Erythromycin. Concomitant medications in two weeks included Omeprazole, fluticasone propionate (FLONASE), famotidine, fluticasone propionate/ salmeterol xinafoate (ADVAIR), biotin. The patient had no other vaccine in four weeks. The patient experienced two events so far of blood in urine. First was the following day which was approx 23 hours after shot (13Mar2021 10:30 AM), then second noticed event of blood in urine was the next morning, approx 44 hours after shot. The patient had not COVID prior vaccination and did not have COVID tested post vaccination. No treatment for the event. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.
Patient's mother stated that she noticed redness, swelling, and warmth to injection site about 24 hours after DTAP vaccine was administered. Patient was taken to local ER when the mother noticed that pt was having a reaction. No medication was given or prescribed by ER. Pt's mother stated that they told her to continue using ice packs. Redness and swelling decreased significantly on 05/05/2022 as per the pt's mother.
HIGH FEVER 104.7F ACCOMPANIED BY HEADACHE FIRST DAY, ADMINISTERED MOTRIN EVERY 6 HOURS AND FEVER HOVERED BETWEEN 101F & 102F, GAVE CHILD ICE-WATER & JUICE TO DRINK, FED COLD FOODS AND KEPT HOME FROM SCHOOL FOR 2 DAYS UNTIL FEVER BROKE.
Patient requested a booster dose.  Patient had aged out of Ped Pfizer 5-11.  Patient needed to receive Pfizer 12 plus.  Patient received Ped Pfizer 5-11. Patient's mother denied the immediate dose of the Pfizer 12 plus.